NASHVILLE, TN - Tennessee Gov. Bill Lee, Tennessee Department of Economic and Community Development Commissioner Bob Rolfe, and USAntibiotics executives announced Monday, Aug. 30, that the business will spend $16 million in Sullivan County to build new manufacturing and R&D facilities.
USAntibiotics is a pharmaceutical manufacturing business that produces, tests, packages, and delivers prescription antibiotics. In Bristol, the initiative will result in the creation of 63 new employment.
Jackson Healthcare purchased the 360,000-square-foot building at 201 Industrial Drive with plans to reopen the former pharmaceutical production plant.
The Department of Homeland Security has designated USAntibiotics as essential infrastructure because it is the only facility in the United States allowed to manufacture Amoxil® and Amoxicillin Clavulanate, also known as Amoxil® and Augmentin®. These are two of the most often given antibiotics in the United States, and this investment will significantly improve the country's ability to generate its own critical medicines.
TNECD has sponsored more than ten economic development initiatives in Sullivan County over the last five years, resulting in more than 1,800 job commitments and almost $700 million in capital investment.
“This investment by USAntibiotics is a win not only for Tennessee but for the entire country. Tennessee is known globally as a hub for the healthcare industry, and we are proud to welcome the only American-made Amoxicillin facility to Bristol,” Gov. Lee said in the announcement
TNECD Commissioner Bob Rolfe is proud to support USAntibiotics in its important mission to manufacture two of the country's most regularly prescribed antibiotics. He believes Tennessee provides a business-friendly climate and talented workforce to firms across the world.
This is original content from NewsBreak’s Creator Program. Join today to publish and share your own content.